The purpose of the company is the development, operation, and commercial exploitation of technological and market-related infrastructures that enable activities in the field of biosciences and other deep science sectors to be structured as programmable and investable assets. The company can, in particular, develop, use, and exploit proprietary protocols, software platforms, and intellectual property to represent datasets, milestones, revenue streams, and licensing rights as traceable digital instruments, as well as to facilitate collaborations, licensing, and financing between research institutions, commercial companies, and investors. The company can participate in other enterprises, as well as acquire, exploit, manage, and dispose of real estate and intangible assets, establish subsidiaries and branches both domestically and abroad, and additionally perform all legal actions that the purpose of the company may entail or that are suitable to promote its development or that of group companies. The company can grant direct or indirect financing to third parties, including companies in which it is directly or indirectly involved, its direct or indirect shareholders, and companies in which these shareholders are directly or indirectly involved, either through loans or other financing, as well as provide security for their liabilities of any kind, including through pledges on or fiduciary transfers of the company's assets or through guarantees of any kind, whether for consideration or not.